Moreover, higher FGF21 and GDF15 circulating levels are associated with age-related diseases such as obesity, cardiovascular disease, insulin resistance, type 2 diabetes, and neurodegeneration [111,113], as well as cancer cachexia [124,125]. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.